Health-Related Quality-of-Life Assessment in Dermatologic Practice: Relevance and Application

Dermatologic Clinics

Volumn 30, Issue 2, 2012, Pages 323-332

  van Cranenburgh, O D ^a   Prinsen, C A C ^a   Sprangers, M A G ^a   Spuls, Ph I ^a   de Korte, J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Chronic skin disease; Clinical practice; Dermatology; HRQoL assessment

Indexed keywords

CLINICAL ASSESSMENT; CLINICAL PRACTICE; DERMATOLOGY; EMPOWERMENT; HEALTH CARE; HUMAN; MEDICAL PRACTICE; MEDICAL TECHNOLOGY; PATIENT DECISION MAKING; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; SELF CONCEPT; SKIN DISEASE; SKINDEX 29; TREATMENT OUTCOME;

DERMATOLOGY; HEALTH STATUS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF LIFE; QUESTIONNAIRES; SKIN DISEASES; TREATMENT OUTCOME;

EID: 84856278444     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.11.004     Document Type: Review

References (41)

1. Krenzer S., Radtke M., Schmitt-Rau K., et al. Characterization of patient-reported outcomes in moderate to severe psoriasis. Dermatology 2011, 223:80-86.
2. Valderas J.M., Alonso J., Guyatt G.H. Measuring patient-reported outcomes: moving from clinical trials into clinical practice. Med J Aust 2008, 189:93-94.
3. Valderas J.M., Kotzeva A., Espallargues M., et al. The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res 2008, 17:179-193.
4. Rapp S.R., Feldman S.R., Exum M.L., et al. Psoriasis causes as much disability as other major medical diseases. JAm Acad Dermatol 1999, 41:401-407.
5. Chren M.M. Interpretation of quality-of-life scores. JInvest Dermatol 2010, 130:1207-1209.
6. Holm E.A., Wulf H.C., Stegmann H., et al. Life quality assessment among patients with atopic eczema. Br J Dermatol 2006, 154:719-725.
7. Prinsen C.A., Lindeboom R., Sprangers M.A., et al. Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors. JInvest Dermatol 2010, 130:1318-1322.
8. Guyatt G.H., Ferrans C.E., Halyard M.Y., et al. Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice. Mayo Clin Proc 2007, 82:1229-1239.
9. Velikova G., Booth L., Smith A.B., et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. JClin Oncol 2004, 22:714-724.
10. Detmar S.B., Muller M.J., Schornagel J.H., et al. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA 2002, 288:3027-3034.
11. Working Group Quality of Life Assessment in Dermatological Practice Kwaliteit van leven assessment in de dermatologische praktijk: een praktische leidraad 2008, Stichting Aquamarijn, Amsterdam.
12. Bozcuk H., Erdogan V., Eken C., et al. Does awareness of diagnosis make any difference to quality of life? Determinants of emotional functioning in a group of cancer patients in Turkey. Support Care Cancer 2002, 10:51-57.
13. Forlani G., Zannoni C., Tarrini G., et al. An empowerment-based educational program improves psychological well-being and health-related quality of life in Type 1 diabetes. J Endocrinol Invest 2006, 29:405-412.
14. Tu Y.C., Wang R.H., Yeh S.H. Relationship between perceived empowerment care and quality of life among elderly residents within nursing homes in Taiwan: a questionnaire survey. Int J Nurs Stud 2006, 43:673-680.
15. Chren M.M., Lasek R.J., Flocke S.A., et al. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997, 133:1433-1440.
16. Picardi A., Abeni D., Melchi C.F., et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000, 143:983-991.
17. Renzi C., Abeni D., Picardi A., et al. Factors associated with patient satisfaction with care among dermatological outpatients. Br J Dermatol 2001, 145:617-623.
18. Sampogna F., Picardi A., Chren M.M., et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 2004, 66:620-624.
19. Richards H.L., Fortune D.G., Griffiths C.E. Adherence to treatment in patients with psoriasis. JEur Acad Dermatol Venereol 2006, 20:370-379.
20. Carroll C.L., Balkrishnan R., Feldman S.R., et al. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005, 22:192-199.
21. Chamlin S.L., Frieden I.J., Williams M.L., et al. Effects of atopic dermatitis on young American children and their families. Pediatrics 2004, 114:607-611.
22. Finlay A.Y., Coles E.C. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995, 132:236-244.
23. Finlay A.Y., Khan G.K. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994, 19:210-216.
24. de Korte J., Mombers F.M., Sprangers M.A., et al. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol 2002, 138:1221-1227.
25. Both H., Essink-Bot M.L., Busschbach J., et al. Critical review of generic and dermatology-specific health-related quality of life instruments. JInvest Dermatol 2007, 127:2726-2739.
26. Chren M.M., Lasek R.J., Quinn L.M., et al. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. JInvest Dermatol 1997, 108:103-107.
27. Abeni D., Picardi A., Pasquini P., et al. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology 2002, 204:43-49.
28. Aksu A.E., Urer M.S., Sabuncu I., et al. Turkish version of Skindex-29. Int J Dermatol 2007, 46:350-355.
29. Augustin M., Wenninger K., Amon U., et al. German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results. Dermatology 2004, 209:14-20.
30. Jones-Caballero M., Penas P.F., Garcia-Diez A., et al. Med Clin (Barc) 2002, 118:5-9. [in Spanish].
31. Leplege A., Ecosse E., Zeller J., et al. Ann Dermatol Venereol 2003, 130:177-183. [in French].
32. Lofland J.H., Schaffer M., Goldfarb N. Evaluating health-related quality of life: cost comparison ofcomputerized touch-screen technology and traditional paper systems. Pharmacotherapy 2000, 20:1390-1395.
33. Goodhart I.M., Ibbotson V., Doane A., et al. Hypopituitary patients prefer a touch-screen to paper quality of life questionnaire. Growth Horm IGF Res 2005, 15:384-387.
34. Gutteling J.J., Busschbach J.J., de Man R.A., et al. Logistic feasibility of health related quality of life measurement in clinical practice: results of a prospective study in a large population of chronic liver patients. Health Qual Life Outcomes 2008, 6:97.
35. Kleinman L., Leidy N.K., Crawley J., et al. Acomparative trial of paper-and-pencil versus computer administration of the Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire. Med Care 2001, 39:181-189.
36. Larsson B.W. Touch-screen versus paper-and-pen questionnaires: effects on patients' evaluations of quality of care. Int J Health Care Qual Assur Inc Leadersh Health Serv 2006, 19:328-338.
37. Velikova G., Wright E.P., Smith A.B., et al. Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. JClin Oncol 1999, 17:998-1007.
38. Wright E.P., Selby P.J., Crawford M., et al. Feasibility and compliance of automated measurement of quality of life in oncology practice. JClin Oncol 2003, 21:374-382.
39. Hongbo Y., Thomas C.L., Harrison M.A., et al. Translating the science of quality of life into practice: What do dermatology life quality index scores mean?. JInvest Dermatol 2005, 125:659-664.
40. Nijsten T., Sampogna F., Abeni D. Categorization of Skindex-29 scores using mixture analysis. Dermatology 2009, 218:151-154.
41. Prinsen C.A., Lindeboom R., Korte J.D. Interpretation of Skindex-29 scores: cutoffs for mild, moderate, and severe impairment of health-related quality of life. JInvest Dermatol 2011, 131:1945-1947.